Product Information

QC MUCUS RLF DM 20-400 MG CPLT is a generic product labeled by Chain Drug Marketing Association, priced at $0.0779 per EA under NDC 83324019550. Its NADAC has been published 73 times since Feb 5, 2025.

The Low Outlier badge above means this manufacturer's average price in the Dextromethorphan Hydrobromide / Guaifenesin market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

QC MUCUS RLF DM 20-400 MG CPLT

Dextromethorphan Hydrobromide / Guaifenesin
$0.0779per EA
Low Outlier
OTC

Strength

20; 400 mg/1; mg/1

NDC

83324019550

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

10/14/2024

Pharmacological Classes

Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists

Price Statistics

The NADAC for QC MUCUS RLF DM 20-400 MG CPLT has been published 73 times since Feb 5, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0779 per EA
All-time high$0.0798 (Mar 11, 2026)
All-time low$0.0771 (Jun 18, 2025)
52-week high$0.0798
52-week low$0.0771
Median price$0.0786
Average price$0.0784
Largest weekly change+2.0% (Feb 18, 2026)
Weeks tracked73
Tracking sinceFeb 5, 2025

Price History

1W

0.0%

1M

-1.4%

3M

-2.2%

6M

-1.0%

1Y

+0.9%

3Y

N/A

5Y

N/A

All

-1.3%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of QC MUCUS RLF DM 20-400 MG CPLT?

The current National Average Drug Acquisition Cost (NADAC) for QC MUCUS RLF DM 20-400 MG CPLT, manufactured by Chain Drug Marketing Association, is $0.0779 per EA (NDC 83324019550), effective Jun 24, 2026.

How has the price of QC MUCUS RLF DM 20-400 MG CPLT changed over time?

Over the history we have for it, the NADAC for QC MUCUS RLF DM 20-400 MG CPLT has held within roughly two percent of its current level. It has been tracked across 73 weekly CMS publications since Feb 5, 2025.

What are the highest and lowest recorded NADAC prices for QC MUCUS RLF DM 20-400 MG CPLT?

Since Feb 5, 2025, the NADAC for QC MUCUS RLF DM 20-400 MG CPLT has ranged from a low of $0.0771 (Jun 18, 2025) to a high of $0.0798 (Mar 11, 2026), with a median of $0.0786 per EA.

Are there cheaper alternatives to QC MUCUS RLF DM 20-400 MG CPLT?

Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QC MUCUS RELIEF DM TABLET, is $0.0766 per EA — about 2% below QC MUCUS RLF DM 20-400 MG CPLT.

Who manufactures QC MUCUS RLF DM 20-400 MG CPLT?

QC MUCUS RLF DM 20-400 MG CPLT (NDC 83324019550) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.